Abstract
Background: Besides changes in pituitary hormones secretion observed during the acute phase of stroke as an adaptive response to injury or an effect of drugs, a true hypopituitarism due to ischemic and/or hemorrhagic damage at the hypothalamus and/or pituitary gland can develop after a stroke.
Case Report: We report a case of a 72-year-old woman showing clinical signs and laboratory data suggesting a secondary adrenal insufficiency following a recent acute brain ischemia. Cortisone therapy significantly improved this pituitary dysfunction.
Conclusions: Clinicians must pay attention to the hypothalamic-pituitary axis in neurocritical patients because hormonal replacement therapy may be life-saving.
Keywords: Adrenal insufficiency, hyponatremia, hypopituitarism, neuro-critical patients.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Hypopituitarism in Neurocritical Patients: A Case Report
Volume: 16 Issue: 1
Author(s): Michele Iovino, Nicola Iovine, Fiorentino Mondillo, Edoardo Guastamacchia, Brunclla Licchelli, Vito A. Giagulli and Vincenzo Triggiani
Affiliation:
Keywords: Adrenal insufficiency, hyponatremia, hypopituitarism, neuro-critical patients.
Abstract: Background: Besides changes in pituitary hormones secretion observed during the acute phase of stroke as an adaptive response to injury or an effect of drugs, a true hypopituitarism due to ischemic and/or hemorrhagic damage at the hypothalamus and/or pituitary gland can develop after a stroke.
Case Report: We report a case of a 72-year-old woman showing clinical signs and laboratory data suggesting a secondary adrenal insufficiency following a recent acute brain ischemia. Cortisone therapy significantly improved this pituitary dysfunction.
Conclusions: Clinicians must pay attention to the hypothalamic-pituitary axis in neurocritical patients because hormonal replacement therapy may be life-saving.
Export Options
About this article
Cite this article as:
Iovino Michele, Iovine Nicola, Mondillo Fiorentino, Guastamacchia Edoardo, Licchelli Brunclla, A. Giagulli Vito and Triggiani Vincenzo, Hypopituitarism in Neurocritical Patients: A Case Report, Endocrine, Metabolic & Immune Disorders - Drug Targets 2016; 16 (1) . https://dx.doi.org/10.2174/1871530315666150930121912
DOI https://dx.doi.org/10.2174/1871530315666150930121912 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 6
Endocrine, Metabolic & Immune Disorders - Drug Targets Organocatalyzed Heterocyclic Transformations In Green Media: A Review
Current Organocatalysis Endovascular vs. Open Repair of Abdominal Aortic Aneurysms and Renal Function
Current Vascular Pharmacology HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Current Cancer Drug Targets Stent-Based Delivered Anti-Proliferative Drugs in the Prevention of Coronary Stent Restenosis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Current Key Points in Management for Severe Community-Acquired Pneumonia
Current Respiratory Medicine Reviews Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension
Current Hypertension Reviews Physiological Functions of NO-Sensitive Guanylyl Cyclase Isoforms
Current Medicinal Chemistry <i>Scaphechinus mirabilis</i> Extract Effectively Inhibits the Proliferation of BPH-1 and LNCaP Prostate Epithelial Cells
The Natural Products Journal Cardiac Biomarkers in Acute Coronary Syndromes: A Review
Current Vascular Pharmacology Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach
Current Pharmaceutical Design Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia
CNS & Neurological Disorders - Drug Targets A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Cognitive Impairment in the Septic Brain
Current Neurovascular Research Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Current Drug Metabolism Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Neuroprotection by Alpha 2-Adrenergic Agonists in Cerebral Ischemia
Current Neuropharmacology